OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Publication Date
Release Date
2020
(4)
2025
(2)
2023
(2)
2021
(2)
2019
(2)
2018
(2)
2013
(2)
2011
(2)
2026
(1)
2022
(1)
2017
(1)
2015
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Clinical courses and outcomes of cerebral toxoplasmosis in HIV-positive patients in Shiraz, Southern Iran: a retrospective study.
Not available
S-EPMC12210869
|
biostudies-literature
Cite
Neo-epidemiological machine learning based method for COVID-19 related estimations.
Not available
S-EPMC10038265
|
biostudies-literature
Cite
Occurrence and distribution of azithromycin in wastewater treatment plants, seawater, and sediments of the northern part of the Persian Gulf around Bushehr port: A comparison with Pre-COVID 19 pandemic.
Not available
S-EPMC9372055
|
biostudies-literature
Cite
Association of severe depression with bone mineral content: a mediation analysis in PERSIAN cohort study.
Not available
S-EPMC12924434
|
biostudies-literature
Cite
Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer.
Not available
S-EPMC10577985
|
biostudies-literature
Cite
Dysregulated LINC01133 expression in laryngeal carcinoma: Prognostic implications and predicted ceRNA interactome.
Not available
S-EPMC11624609
|
biostudies-literature
Cite
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.
Not available
S-EPMC3625710
|
biostudies-literature
Cite
Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study.
Not available
S-EPMC3542410
|
biostudies-literature
Cite
Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma.
Not available
S-EPMC3717559
|
biostudies-literature
Cite
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma.
Not available
S-EPMC4639410
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets